130 related articles for article (PubMed ID: 33645326)
1. Assessing the impact of chemotherapy-induced nausea and vomiting on patients' quality of life: An Arabic version of the Functional Living Index-Emesis.
Alhammad AM; Alkhudair N; Alzaidi R; Almosabhi LS; Aljawadi MH
J Oncol Pharm Pract; 2022 Apr; 28(3):535-541. PubMed ID: 33645326
[TBL] [Abstract][Full Text] [Related]
2. Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall.
Martin AR; Pearson JD; Cai B; Elmer M; Horgan K; Lindley C
Support Care Cancer; 2003 Aug; 11(8):522-7. PubMed ID: 12827483
[TBL] [Abstract][Full Text] [Related]
3. Quality of life consequences of chemotherapy-induced emesis.
Lindley CM; Hirsch JD; O'Neill CV; Transau MC; Gilbert CS; Osterhaus JT
Qual Life Res; 1992 Oct; 1(5):331-40. PubMed ID: 1299465
[TBL] [Abstract][Full Text] [Related]
4. [Development of a Japanese version of the FLIE].
Satou A; Yamazaki T; Nukariya N; Nakamachi M; Shimada K; Matsukawa M; Kurihara M
Gan To Kagaku Ryoho; 2002 Feb; 29(2):281-91. PubMed ID: 11865635
[TBL] [Abstract][Full Text] [Related]
5. Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life.
Abunahlah N; Sancar M; Dane F; Özyavuz MK
Int J Clin Pharm; 2016 Dec; 38(6):1464-1476. PubMed ID: 27796777
[TBL] [Abstract][Full Text] [Related]
6. Measuring the maintenance of daily life activities using the functional living index-emesis (FLIE) in patients receiving moderately emetogenic chemotherapy.
Decker GM; DeMeyer ES; Kisko DL
J Support Oncol; 2006 Jan; 4(1):35-41, 52. PubMed ID: 16444851
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the 3-day recall period for the Functional Life Index-Emesis (FLIE).
Wan BA; Drost L; Ganesh V; Zhang L; Yee C; Tsao M; Barnes E; Pasetka M; DeAngelis C; Chow E
Ann Palliat Med; 2018 Oct; 7(4):393-403. PubMed ID: 30180722
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study.
Hilarius DL; Kloeg PH; van der Wall E; van den Heuvel JJ; Gundy CM; Aaronson NK
Support Care Cancer; 2012 Jan; 20(1):107-17. PubMed ID: 21258948
[TBL] [Abstract][Full Text] [Related]
9. Symptom clusters of gastrointestinal cancer patients undergoing radiotherapy using the Functional Living Index-Emesis (FLIE) quality-of-life tool.
Poon M; Dennis K; DeAngelis C; Chung H; Stinson J; Zhang L; Bedard G; Wong E; Popovic M; Lao N; Pulenzas N; Wong S; Cheon P; Chow E
Support Care Cancer; 2015 Sep; 23(9):2589-98. PubMed ID: 25620759
[TBL] [Abstract][Full Text] [Related]
10. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
[TBL] [Abstract][Full Text] [Related]
11. Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy.
Chasen M; Urban L; Schnadig I; Rapoport B; Powers D; Arora S; Navari R; Schwartzberg L; Gridelli C
Support Care Cancer; 2017 Jan; 25(1):85-92. PubMed ID: 27557833
[TBL] [Abstract][Full Text] [Related]
12. Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial.
Pérol D; Provençal J; Hardy-Bessard AC; Coeffic D; Jacquin JP; Agostini C; Bachelot T; Guastalla JP; Pivot X; Martin JP; Bajard A; Ray-Coquard I
BMC Cancer; 2012 Dec; 12():603. PubMed ID: 23244208
[TBL] [Abstract][Full Text] [Related]
13. Relationship between Helicobacter pylori infection and vomiting induced by gastrointestinal cancer chemotherapy.
Yao Y; Ji C; He Y; Pan Y
Intern Med J; 2017 Jul; 47(7):792-797. PubMed ID: 28321977
[TBL] [Abstract][Full Text] [Related]
14. Impact of radiation-induced nausea and vomiting on quality of life.
Yee C; Drost L; Zhang L; Wan BA; Ganesh V; Tsao M; Barnes E; Pasetka M; DeAngelis C; Chow E
Support Care Cancer; 2018 Nov; 26(11):3959-3966. PubMed ID: 29808378
[TBL] [Abstract][Full Text] [Related]
15. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.
Bloechl-Daum B; Deuson RR; Mavros P; Hansen M; Herrstedt J
J Clin Oncol; 2006 Sep; 24(27):4472-8. PubMed ID: 16983116
[TBL] [Abstract][Full Text] [Related]
16. Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: survey of five Canadian centres.
O'Brien BJ; Rusthoven J; Rocchi A; Latreille J; Fine S; Vandenberg T; Laberge F
CMAJ; 1993 Aug; 149(3):296-302. PubMed ID: 8339175
[TBL] [Abstract][Full Text] [Related]
17. Mail-in questionnaire for monitoring nausea and vomiting in oncology outpatients.
Mullin SM; Fletcher DM; Tyler LS
Am J Health Syst Pharm; 1998 Sep; 55(18):1903-6. PubMed ID: 9784770
[TBL] [Abstract][Full Text] [Related]
18. Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study.
Grassi L; Berardi MA; Ruffilli F; Meggiolaro E; Andritsch E; Sirgo A; Caruso R; Juan Linares E; Bellé M; Massarenti S; Nanni MG;
Psychother Psychosom; 2015; 84(6):339-47. PubMed ID: 26402426
[TBL] [Abstract][Full Text] [Related]
19. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
[TBL] [Abstract][Full Text] [Related]
20. The impact of chemotherapy-induced nausea and vomiting on health-related quality of life.
Ballatori E; Roila F; Ruggeri B; Betti M; Sarti S; Soru G; Cruciani G; Di Maio M; Andrea B; Deuson RR
Support Care Cancer; 2007 Feb; 15(2):179-85. PubMed ID: 16941136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
